Photo from Karine Tawagi/X
Sep 30, 2024, 15:09
Karine Tawagi: Prostate CA panel at Uromigos on radioligands and future T cell engagers
Karine Tawagi, University of Illinois Chicago, shared a post on X:
“Prostate CA panel at Uromigos day 2 on:
radioligands:
-clinically meaningful SUV threshold?
-pre-chemo Lu-617 approvals in real world?
-issue with cytopenias -individualized dosimetry? PET q2cycles?
The future T cell engagers (ph1 Tarlatamab DLL3 in NEPC), beware CRS.”
Source: Karine Tawagi/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 30, 2024, 15:06
Sep 30, 2024, 14:58
Sep 30, 2024, 14:37
Sep 30, 2024, 14:29
Sep 30, 2024, 14:01
Sep 30, 2024, 10:40